|
|
Volumn 2, Issue 5, 2005, Pages 225-
|
|
Atrial fibrillation: An epidemiologic, scientific and clinical challenge
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
FIBRINOGEN;
AGING;
CARDIOVERSION;
CORONARY ARTERY BYPASS SURGERY;
DIABETES MELLITUS;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DISEASE DURATION;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
ERYTHROCYTE AGGREGATION;
HEALTH CARE COST;
HEART ATRIUM FIBRILLATION;
HEART FAILURE;
HEART MUSCLE;
HOSPITAL ADMISSION;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
MYOCARDITIS;
NATIONAL HEALTH SERVICE;
POSTOPERATIVE COMPLICATION;
PRACTICE GUIDELINE;
PREVALENCE;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RISK ASSESSMENT;
SINUS RHYTHM;
STROKE;
SURVIVAL RATE;
THROMBOSIS;
VALVULAR HEART DISEASE;
AGE FACTORS;
AGED;
ATRIAL FIBRILLATION;
HUMANS;
|
|
EID: 20544449952
PISSN: 17434297
EISSN: None
Source Type: Journal
DOI: 10.1038/ncpcardio0199 Document Type: Editorial |
|
Times cited : (12)
|
|
References (0)
|